Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
Repeatability of quantitative [electronic resource] by
- Kramer, G M
- Liu, Y
- de Langen, A J
- Jansma, E P
- Trigonis, I
- Asselin, M-C
- Jackson, A
- Kenny, L
- Aboagye, E O
- Hoekstra, O S
- Boellaard, R
Producer: 20181214
In:
European journal of nuclear medicine and molecular imaging vol. 45
Availability: No items available.
|
|
|
5.
|
Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer. [electronic resource] by
- van Veggel, B
- Madeira R Santos, J F Vilacha
- Hashemi, S M S
- Paats, M S
- Monkhorst, K
- Heideman, D A M
- Groves, M
- Radonic, T
- Smit, E F
- Schuuring, E
- van der Wekken, A J
- de Langen, A J
Producer: 20210406
In:
Lung cancer (Amsterdam, Netherlands) vol. 141
Availability: No items available.
|
|
|
6.
|
First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging. [electronic resource] by
- Dingemans, A-M C
- de Langen, A J
- van den Boogaart, V
- Marcus, J T
- Backes, W H
- Scholtens, H T G M
- van Tinteren, H
- Hoekstra, O S
- Pruim, J
- Brans, B
- Thunnissen, F B
- Smit, E F
- Groen, H J M
Producer: 20110614
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
|
7.
|
Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer. [electronic resource] by
- van der Wekken, A J
- Pelgrim, R
- 't Hart, N
- Werner, N
- Mastik, M F
- Hendriks, L
- van der Heijden, E H F M
- Looijen-Salamon, M
- de Langen, A J
- Staal-van den Brekel, J
- Riemersma, S
- van den Borne, B E
- Speel, E J M
- Dingemans, A-M C
- Hiltermann, T J N
- van den Berg, A
- Timens, W
- Schuuring, E
- Groen, H J M
Producer: 20180619
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 23
Availability: No items available.
|
|
|
8.
|
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer. [electronic resource] by
- Niemeijer, A N
- Leung, D
- Huisman, M C
- Bahce, I
- Hoekstra, O S
- van Dongen, G A M S
- Boellaard, R
- Du, S
- Hayes, W
- Smith, R
- Windhorst, A D
- Hendrikse, N H
- Poot, A
- Vugts, D J
- Thunnissen, E
- Morin, P
- Lipovsek, D
- Donnelly, D J
- Bonacorsi, S J
- Velasquez, L M
- de Gruijl, T D
- Smit, E F
- de Langen, A J
Producer: 20190422
In:
Nature communications vol. 9
Availability: No items available.
|
|
|
9.
|
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs. [electronic resource] by
- van der Velden, D L
- Hoes, L R
- van der Wijngaart, H
- van Berge Henegouwen, J M
- van Werkhoven, E
- Roepman, P
- Schilsky, R L
- de Leng, W W J
- Huitema, A D R
- Nuijen, B
- Nederlof, P M
- van Herpen, C M L
- de Groot, D J A
- Devriese, L A
- Hoeben, A
- de Jonge, M J A
- Chalabi, M
- Smit, E F
- de Langen, A J
- Mehra, N
- Labots, M
- Kapiteijn, E
- Sleijfer, S
- Cuppen, E
- Verheul, H M W
- Gelderblom, H
- Voest, E E
Producer: 20191120
In:
Nature vol. 574
Availability: No items available.
|